Recent News

• 03.30.2026 - Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual Meeting on Women's Cancer
• 03.12.2026 - Anixa Biosciences Featured on Water Tower Research Healthcare Happenings Podcast
• 03.11.2026 - 8-K - Current report
• 03.09.2026 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 03.09.2026 - Anixa Biosciences Receives Notice of Allowance from Korean Ministry of Intellectual Property (MOIP) for Patent Covering Breast Cancer Vaccine Technology
• 03.02.2026 - Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
• 02.23.2026 - Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
• 02.09.2026 - 8-K - Current report
• 02.09.2026 - Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
• 02.04.2026 - CORRESP - Correspondence

Recent Filings

• 03.11.2026 - EX-99.1 EX-99.1
• 03.11.2026 - 8-K Current report
• 03.09.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 02.09.2026 - EX-99.1 EX-99.1
• 02.09.2026 - 8-K Current report
• 01.29.2026 - 4 Statement of changes in beneficial ownership of securities